Extracorporeal Shock Wave Therapy for Dysmenorrhea
the Efficacy of Extracorporeal Shock Wave Therapy for Primary Dysmenorrhea
1 other identifier
interventional
50
1 country
1
Brief Summary
purpose of this study to investigate the effect of Extracorporeal shock wave therapy on pain and prostaglandin level in patient with primary dysmenorrhea
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 12, 2020
CompletedFirst Submitted
Initial submission to the registry
November 22, 2020
CompletedFirst Posted
Study publicly available on registry
December 10, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 24, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 27, 2021
CompletedMarch 24, 2021
March 1, 2021
3 months
November 22, 2020
March 20, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
numerical rating scale
Numeric rating scale will be 10 cm digital line with 0 (zero) representing feeling no pain and 10 representing feeling the worst pain, was used to assess the severity of the pain before and after treatment for all females in both groups (A\&B). measurement will done twice first one at baseline(will be considered as pre treatment measure) and 2nd on e at 3rd menstrual cycle ( will be considered as post treatment measure)
3 months
Secondary Outcomes (1)
prostaglandin
3months
Study Arms (2)
shock wave
EXPERIMENTALshock wave for primary dysmenorrhea for study group along side to dietary modification
dietary modification
ACTIVE COMPARATORdietary modification for primary dysmenorrhea for control group
Interventions
Intervention group is by shock wave therapy. A radial shock wave device (EME, ITALY) was used. for 4 sessions (one session before the expected day of period and session per day for day1 , day 2 and day 3 of each menstrual cycle) for three successive periods.
Participants will receive dietary modification for three consecutive months dietary modification will be low caffeine and high water and liquids intake and reduce the uptake of fast food, should be followed for 3 months
Eligibility Criteria
You may qualify if:
- ages ranged between18 - 25 years old.
- body mass index (BMI) will not exceed 30kg/m2.
- females will be diagnosed by the physician as primary dysmenorrhea.
You may not qualify if:
- Secondary dysmenorrhea .
- Mental health problem such as depression and anxiety.
- Irregular periods
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
MTI
Cairo, Egypt
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principle investigator
Study Record Dates
First Submitted
November 22, 2020
First Posted
December 10, 2020
Study Start
September 12, 2020
Primary Completion
December 24, 2020
Study Completion
January 27, 2021
Last Updated
March 24, 2021
Record last verified: 2021-03